Virtual Medicinal Product (VMP) - Erythromycin 4% gel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Erythromycin 4% gel | Start Date 21-01-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- D10AF02
- BNF Codes
-
- BNF code 13060100
| Code | Start Date | End Date |
|---|---|---|
| 41739511000001105 | 02-05-2023 | |
| 332351009 | 21-01-2003 | 01-05-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Erythromycin | Based on Ingredient Substance | 40 mg | 1 gram |
Name
Erythromycin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
40
Strength and UOM (Dmr)
1
Parent Products
-
VTMErythromycin
-
VMP(Current) Erythromycin 4% gel
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 gram | ||
| 30 gram |